News

Revolutionary three-in-one blood test could change treatment for advanced stages of disease, say scientists.

In previous studies, researchers linked infant brain anatomy differences to autism diagnoses at age two. Now they show differences in functional connections between brain regions at 6 months to predict autism at age two.

A team of researchers is using breakthrough gene-editing technology to develop a new screening tool for Parkinson's disease, a debilitating degenerative disorder of the nervous system. The technology allows scientists in the lab to 'light up' and then monitor a brain protein called alpha-synuclein that has been associated with Parkinson's.

Researchers from MIT's Media Lab have developed a tattoo ink that changes colour according to varying glucose and pH levels inside the body.

Changes in immune activity appear to signal a growing brain tumor five years before symptoms arise, new research has found.

Researchers found that a molecule called PD-L1, which is blocked by the immunotherapy drug nivolumab, acts not only on immune cells but also on the nerve cells that signal pain. That insight could lead to a simple test that measures subtle differences in pain sensitivity to gauge whether or not a cancer patient is responding to immunotherapy. This study also identifies PD-L1 as a previously unrecognized neuromodulator and pain inhibitor.

A new plasmonic sensor developed by researchers at the University of Illinois at Urbana-Champaign will serve as a reliable early detection of biomarkers for many forms of cancer and eventually other diseases.

IsoPSA assay can help in determining the need for prostate biopsy for patients

Cheap diamond-based sensors are set to make it possible for most hospitals to diagnose heart disease and brain conditions using magnetic fields.

Understanding the signals of one's own organism can also alleviate the symptoms of serious ailments, for example, schizophrenia or autism.